GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jolt Health Inc (XCNQ:JOLT) » Definitions » EV-to-EBIT

Jolt Health (XCNQ:JOLT) EV-to-EBIT : -1.16 (As of Jun. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jolt Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jolt Health's Enterprise Value is C$0.79 Mil. Jolt Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.68 Mil. Therefore, Jolt Health's EV-to-EBIT for today is -1.16.

The historical rank and industry rank for Jolt Health's EV-to-EBIT or its related term are showing as below:

XCNQ:JOLT' s EV-to-EBIT Range Over the Past 10 Years
Min: -79.28   Med: -9.26   Max: 2058.6
Current: -1.16

During the past 13 years, the highest EV-to-EBIT of Jolt Health was 2058.60. The lowest was -79.28. And the median was -9.26.

XCNQ:JOLT's EV-to-EBIT is ranked worse than
100% of 668 companies
in the Drug Manufacturers industry
Industry Median: 16.495 vs XCNQ:JOLT: -1.16

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Jolt Health's Enterprise Value for the quarter that ended in Mar. 2024 was C$0.36 Mil. Jolt Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.68 Mil. Jolt Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -188.16%.


Jolt Health EV-to-EBIT Historical Data

The historical data trend for Jolt Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jolt Health EV-to-EBIT Chart

Jolt Health Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.46 -49.36 -1.15 -0.74 -0.51

Jolt Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.40 -0.15 -0.51 -0.53

Competitive Comparison of Jolt Health's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Jolt Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jolt Health's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jolt Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jolt Health's EV-to-EBIT falls into.



Jolt Health EV-to-EBIT Calculation

Jolt Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.788/-0.682
=-1.16

Jolt Health's current Enterprise Value is C$0.79 Mil.
Jolt Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jolt Health  (XCNQ:JOLT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Jolt Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-0.682/0.36245
=-188.16 %

Jolt Health's Enterprise Value for the quarter that ended in Mar. 2024 was C$0.36 Mil.
Jolt Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jolt Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Jolt Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jolt Health (XCNQ:JOLT) Business Description

Traded in Other Exchanges
Address
355 Burrard Street, Suite 1780, Marine Building, Vancouver, BC, CAN, V6C 2G8
Jolt Health Inc, formerly Love Pharma Inc is a licensee of certain technologies relating to certain controlled substances and pharmaceutical-grade therapeutics. The company is investigating business opportunities in other industries however has not reached a definitive decision to pursue alternative lines of business.

Jolt Health (XCNQ:JOLT) Headlines

No Headlines